scorecardresearch
Tuesday, April 23, 2024
Support Our Journalism
HomeIndiaCentral govt refutes reports of Covid vaccine shortage in Maharashtra

Central govt refutes reports of Covid vaccine shortage in Maharashtra

Follow Us :
Text Size:

New Delhi, Jan 14 (PTI) Refuting media reports on COVID-19 vaccine shortage in Maharashtra, the Health Ministry said the state had over 24 lakh unutilised doses of Covaxin and received an additional 6.35 lakh doses on Friday.

According to the media reports, the state government is unable to increase the pace of vaccination due to a shortage in vaccine availability.

“As per their weekly consumption data available on Co-WIN, the average consumption by Maharashtra for Covaxin to cover the eligible beneficiaries for 15-17 years and for precaution dose is almost 2.94 lakh doses per day. Therefore, the state has adequate vaccine doses for about 10 days to cover the eligible beneficiaries with Covaxin,” the ministry said in a statement.

“Furthermore, for Covishield, the state has 1.24 crore unutilised and balance doses available as on date. With an average consumption of 3.57 lakhs per day, this will sustain for more than 30 days for the beneficiaries to be vaccinated using the vaccine,” it said.

Hence, the media reports are not factually correct and do not reflect the correct picture of the available stock of balance and unutilised Covid vaccine doses with Maharashtra, the ministry said. PTI UZM SMN SMN

This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content.

Subscribe to our channels on YouTube, Telegram & WhatsApp

Support Our Journalism

India needs fair, non-hyphenated and questioning journalism, packed with on-ground reporting. ThePrint – with exceptional reporters, columnists and editors – is doing just that.

Sustaining this needs support from wonderful readers like you.

Whether you live in India or overseas, you can take a paid subscription by clicking here.

Support Our Journalism

  • Tags

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular